SLP
Overvalued by 23.5% based on the discounted cash flow analysis.
Market cap | $887.53 Million |
---|---|
Enterprise Value | $779.03 Million |
Dividend Yield | $0.2389 (0.54%) |
Earnings per Share | $0.52 |
Beta | 1.02 |
Outstanding Shares | 19,984,945 |
Avg 30 Day Volume | 147,065 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 84.4 |
---|---|
PEG | -2429.5 |
Price to Sales | 15.22 |
Price to Book Ratio | 5.71 |
Enterprise Value to Revenue | 12.05 |
Enterprise Value to EBIT | 84.54 |
Enterprise Value to Net Income | 74 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...